Differential effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine
- PMID: 1718013
- DOI: 10.1007/BF02246042
Differential effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine
Abstract
The effects of L-type calcium channel blockers and stimulants on naloxone-precipitated withdrawal in mice acutely dependent on morphine were evaluated. Verapamil (10-80 mg/kg), diltiazem (20-120 mg/kg) and nicardipine (20-160 mg/kg), when administered subcutaneously, produced a dose-dependent reduction in forepaw tremor and weight loss during the abstinence reaction; jumping was also reduced by all three drugs, although the effect was not statistically significant in the case of nicardipine. By contrast, the calcium agonist Bay K 8644 (0.5-2 mg/kg, SC) increased forepaw tremor and weight loss, although this latter effect did not reach statistical significance. The effects of the calcium channel active drugs on the rotarod test were also explored, no correlation appearing with the results observed in abstinence (except for the jumping response), which suggests that the withdrawal results are not influenced by motor incoordination or unspecific CNS depression. These findings suggest that L-type calcium channels probably play an important role in withdrawal after acute morphine dependence. Taken together with other observations in chronic models, these results show that calcium channels are similarly involved in morphine abstinence after acute and chronic dependence, in contrast to the differences in the content and uptake of neuronal calcium induced by morphine under both conditions.
Similar articles
-
Role of L-type calcium channels on yohimbine-precipitated clonidine withdrawal in vivo and in vitro.Naunyn Schmiedebergs Arch Pharmacol. 1993 Dec;348(6):601-7. doi: 10.1007/BF00167236. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 7510854
-
Differential effects of calcium channel blockers and stimulants on morphine withdrawal in vitro.Eur J Pharmacol. 1988 Jul 26;152(1-2):175-8. doi: 10.1016/0014-2999(88)90852-7. Eur J Pharmacol. 1988. PMID: 2463173
-
Mitigating morphine dependence and withdrawal: The role of venlafaxine and calcium channel blockers in mitochondrial damage and oxidative stress in the brain.Brain Res Bull. 2025 Jun 15;226:111364. doi: 10.1016/j.brainresbull.2025.111364. Epub 2025 Apr 27. Brain Res Bull. 2025. PMID: 40300656
-
Effects of peripheral and central administration of calcium channel blockers in the naloxone-precipitated abstinence syndrome in morphine-dependent rats.Eur J Pharmacol. 1987 May 7;137(1):9-13. doi: 10.1016/0014-2999(87)90176-2. Eur J Pharmacol. 1987. PMID: 3609136
-
Effect of nimodipine, diltiazem and BAY K 8644 on the behavioural and neurochemical changes associated with naloxone-precipitated withdrawal in the rat. A comparison with clonidine.Gen Pharmacol. 1993 Jan;24(1):35-41. doi: 10.1016/0306-3623(93)90008-l. Gen Pharmacol. 1993. PMID: 7683298
Cited by
-
Feasibility and Preliminary Efficacy of Isradipine During Outpatient Buprenorphine Stabilization and Detoxification: A Pilot Randomized, Placebo-Controlled Trial.Subst Abuse. 2020 Nov 23;14:1178221820970926. doi: 10.1177/1178221820970926. eCollection 2020. Subst Abuse. 2020. PMID: 33281447 Free PMC article.
-
Randomized, placebo-controlled pilot trial of gabapentin during an outpatient, buprenorphine-assisted detoxification procedure.Exp Clin Psychopharmacol. 2013 Aug;21(4):294-302. doi: 10.1037/a0033724. Epub 2013 Jul 15. Exp Clin Psychopharmacol. 2013. PMID: 23855333 Free PMC article. Clinical Trial.
-
Role of calcium in morphine dependence and naloxone-precipitated withdrawal in mice.J Exp Pharmacol. 2011 Feb 18;3:7-12. doi: 10.2147/JEP.S15240. eCollection 2011. J Exp Pharmacol. 2011. PMID: 27186105 Free PMC article.
-
Role of L-type calcium channels on yohimbine-precipitated clonidine withdrawal in vivo and in vitro.Naunyn Schmiedebergs Arch Pharmacol. 1993 Dec;348(6):601-7. doi: 10.1007/BF00167236. Naunyn Schmiedebergs Arch Pharmacol. 1993. PMID: 7510854
-
Effects of diltiazem, a Ca2+ channel blocker, on naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats.Psychopharmacology (Berl). 1996 May;125(2):135-40. doi: 10.1007/BF02249412. Psychopharmacology (Berl). 1996. PMID: 8783387
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources